Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan, ROC.
Oral Oncol. 2011 Nov;47(11):1085-91. doi: 10.1016/j.oraloncology.2011.07.018. Epub 2011 Aug 15.
The prognosis of well-differentiated oral cavity squamous cell carcinoma (OSCC) is better than less-well-differentiated neoplasms. The aim of this retrospective study was to identify prognostic factors in patients with well-differentiated OSCC. The 5-year outcomes of 467 patients with well-differentiated OSCC who underwent radical surgery and neck dissection were analyzed. In the entire cohort, the presence of pathological node metastases (pN+ vs. pN0) was an independent predictor of 5-year outcomes. In pN0 patients, tumor depth (≥8 mm) was the only independently prognostic factor for 5-year survival rates on multivariable analysis (disease-free survival [DFS], P=0.001, hazard ratio [HR]=2.634, 95% confidence interval [95% CI]=1.496-4.636; disease-specific survival [DSS], P<0.001, HR=6.794, 95% CI=2.364-19.525). In pN+ patients, level IV/V neck nodal metastases (DFS, P<0.001, HR=47.483, 95% CI=8.942-252.122; DSS, P<0.001, HR=14.301, 95% CI=5.337-38.323), and ≥3 positive nodes (DFS, P=0.037, HR=2.107, 95% CI=1.047-4.242; DSS, P=0.044, HR=2.093, 95% CI=1.020-4.295) were independently associated with 5-year outcomes. Our results suggest that a tailored treatment approach in well-differentiated OSCC patients should take into account the presence of either pN0 or pN+ disease.
高分化口腔鳞状细胞癌(OSCC)的预后优于低分化肿瘤。本回顾性研究旨在确定高分化 OSCC 患者的预后因素。对 467 例接受根治性手术和颈部清扫术的高分化 OSCC 患者的 5 年结果进行了分析。在整个队列中,病理性淋巴结转移(pN+与 pN0)的存在是 5 年结果的独立预测因素。在 pN0 患者中,肿瘤深度(≥8mm)是多变量分析中 5 年生存率的唯一独立预后因素(无病生存率[DFS],P=0.001,风险比[HR]=2.634,95%置信区间[95%CI]=1.496-4.636;疾病特异性生存率[DSS],P<0.001,HR=6.794,95%CI=2.364-19.525)。在 pN+患者中,IV/V 颈淋巴结转移(DFS,P<0.001,HR=47.483,95%CI=8.942-252.122;DSS,P<0.001,HR=14.301,95%CI=5.337-38.323)和≥3 个阳性淋巴结(DFS,P=0.037,HR=2.107,95%CI=1.047-4.242;DSS,P=0.044,HR=2.093,95%CI=1.020-4.295)与 5 年结果独立相关。我们的研究结果表明,高分化 OSCC 患者的个体化治疗方法应考虑是否存在 pN0 或 pN+疾病。